Agilent Technologies Inc (A) : Exxonmobil Investment Management Inc Tx reduced its stake in Agilent Technologies Inc by 2.03% during the most recent quarter end. The investment management company now holds a total of 83,117 shares of Agilent Technologies Inc which is valued at $3,938,083 after selling 1,726 shares in Agilent Technologies Inc , the firm said in a disclosure report filed with the SEC on Oct 7, 2016.Agilent Technologies Inc makes up approximately 0.08% of Exxonmobil Investment Management Inc Tx’s portfolio.
Other Hedge Funds, Including , Advisory Services Network boosted its stake in A in the latest quarter, The investment management firm added 91 additional shares and now holds a total of 142 shares of Agilent Technologies Inc which is valued at $6,728.Chevy Chase Trust Holdings reduced its stake in A by selling 8,868 shares or 3.14% in the most recent quarter. The Hedge Fund company now holds 273,818 shares of A which is valued at $12,910,519. Agilent Technologies Inc makes up approx 0.07% of Chevy Chase Trust Holdings’s portfolio.Independent Portfolio Consultants reduced its stake in A by selling 2,030 shares or 70.61% in the most recent quarter. The Hedge Fund company now holds 845 shares of A which is valued at $39,842. Agilent Technologies Inc makes up approx 0.01% of Independent Portfolio Consultants’s portfolio. Eqis Capital Management added A to its portfolio by purchasing 4,475 company shares during the most recent quarter which is valued at $210,996. Agilent Technologies Inc makes up approx 0.01% of Eqis Capital Management’s portfolio.Cullinan Associates Inc reduced its stake in A by selling 350 shares or 0.88% in the most recent quarter. The Hedge Fund company now holds 39,550 shares of A which is valued at $1,864,783. Agilent Technologies Inc makes up approx 0.16% of Cullinan Associates Inc’s portfolio.
Agilent Technologies Inc opened for trading at $47.33 and hit $47.49 on the upside on Friday, eventually ending the session at $47.38, with a gain of 0.17% or 0.08 points. The heightened volatility saw the trading volume jump to 16,63,127 shares. Company has a market cap of $15,369 M.
On the company’s financial health, Agilent Technologies Inc reported $0.49 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 17, 2016. Analyst had a consensus of $0.47. The company had revenue of $1044.00 million for the quarter, compared to analysts expectations of $1046.16 million. The company’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.44 EPS.
Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.